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Many academic laboratories across the world 
may still hold stocks of bacteria, viruses, fungi 
and parasites that are (many) decades old. These 
precious isolates are most probably frozen and 
lying forgotten at the back of a freezer, or freeze 
dried in glass vials and sitting gathering dust in 
the corner of cupboards and store rooms within 
microbiological laboratories across the world. 
Significantly, these microorganisms will most 
likely be preserved along with only a limited 
amount of detailed epidemiological data, which 
means that these ‘data-poor’ isolates (lacking all 
but basic epidemiological data) are very likely 
to be discarded due to their perceived lack of 
scientific value, possibly to make room for the 
storage of more recent isolates, to reduce storage 
costs, or for the decommissioning or rehousing of 
microbiological laboratories. Importantly, even 
if these data-poor microorganisms are eventually 
investigated by scientists, the research results 
obtained will almost invariably be rejected for 
publication by scientific journals due to a per-
ceived lack of scientific significance or interest. 
Should we really be complacent in allowing these 
specimens and their valuable, albeit ‘data poor’, 
information to be lost for future generations? 
After all, these isolates represent an untapped 
resource of biological and genetic information 
for future generations, which once discarded 
cannot be retrieved. Why are scientists and 
scientific journal editors not discussing this 
issue and providing guidance, collaboration, 
research and publishing opportunities for data-
poor microorganisms? Here the author explains 
his viewpoint and provides access to a simple 
website [1] for the exchange of basic information 
on data-poor isolates and for the promotion of 
this subject.
Definitions
In the context of this perspective article, ‘data-
poor’ microorganisms means microorganisms 
collected a minimum of 5 years ago, where some 
or all of the accompanying epidemiological data 
is missing. That said, these data-poor micro-
organisms should still retain some essential epi-
demiological information, country of origin and 
decade of isolation as an absolute minimum. In 
this context, genus and species names do not have 
to be known as these can be readily determined 
after culture and identification (e.g., via the use 
of matrix-assisted laser desorption/ionization 
TOF mass spectrometry). Of course, it is also 
possible to include data-poor microorganisms in 
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this definition which possess more refined epi-
demiological data, such as region of origin, year 
of isolation, genus and species etc. However, this 
article is specifically concerned with those isolates 
where ‘epidemiologically rich’ research involving 
detailed and accurate geo graphical and chrono-
logical epidemiological data is not available and 
where there is a high risk of the data-poor iso-
lates being discarded due to a perceived lack of 
scientific value. Admittedly, this definition is 
somewhat arbitrary and deliberately excludes 
data-poor microorganisms that have been 
collected less than 5 years ago, largely because 
it is presumed that advances in computer-
based data storage technology means that data-
poor micro organisms less than 5 years old are 
becoming much less likely to exist. Further, 
techniques such as whole-genome sequencing 
(WGS) are beginning to be routinely used to 
characterize the epidemiological relationships 
between hospital outbreaks of infection [2] or 
the epidemiology of foodborne-disease out-
breaks [3], which means that there is currently 
more emphasis on collecting and correctly 
storing microbiologically-linked epidemiological 
data. Of course, data-poor microorganisms col-
lected less than 5 years ago may still represent 
scientifically interesting isolates if they possess 
rare genotypic or phenotypic characteristics.
Data loss
The lack of explicit epidemiological information 
for ‘data-poor’ microorganisms may frequently 
be traced back to the fact that at the time of 
isolation, the standard method for recording 
clinical information was pen and paper, and 
that after decades of storage, these paper files 
(but not the relevant microbiological isolates) 
were somehow ‘lost’ to their original owner. This 
process of ‘losing’ clinical information could be 
associated with the simple degradation of paper 
files over time, the disposal of the paper files after 
the relevant microbiologist has obtained alterna-
tive employment or the disposal of the paper files 
after the microbiologist has retired. Exacerbating 
this issue is the fact that the relevant paper files 
would be stored separately from the microbial 
isolates, meaning that the link between the paper 
data and the microbial isolates is lost over many 
years of storage. Additionally, psychologically 
speaking, microbiologists may generally attach 
less significance to disposing of ‘pieces of paper’ 
rather than actual microbial isolates themselves. 
Interestingly, the fact that clinical or diagnostic 
study records are currently stored electronically 
rather than on paper does not necessarily mean 
that this problem will disappear, as pressing 
the ‘delete’ key on data stored in a computer 
is actually much easier than the physical act of 
disposing of paper in a waste bin. However, it is 
now much easier to include all of the informa-
tion obtained from a clinical or diagnostic study 
within a single document on a computer and to 
easily make back-ups of large data files without 
the chance of individual pieces of paper being 
lost or misplaced. Of course, using a computer 
in conjunction with single large data files also 
means that lots of data can be easily deleted or 
lost perhaps due to computer errors that lead to 
disk formatting or the loss of a data file’s pass-
word over time, for example, after the retirement 
of the respective data manager. Additionally, 
large data files can be stored and conveniently 
transported on ‘memory sticks’ and one of the 
problems of using memory sticks is the fact that 
they are small and very easy to transport (and 
therefore very easy to lose), as well as the fact 
that (accidentally) deleting large amounts of 
information on a memory stick is much easier 
than (accidentally) deleting several volumes of 
paper records.
Contextualization & scientific dogma
So how important is the presence of epide-
miologically rich data within the context of 
micro biology, scientif ic research and the 
advancement of knowledge? This depends on 
contex tualization or the actual context in which 
the data is placed. Currently, it is very easy to 
say that data-poor microorganisms possess 
no real publishable value because of the lack 
of precise clinical or diagnostic information 
accompanying the isolates. There currently 
exists therefore a tendency to ignore research on 
data-poor microorganisms and to risk simply 
discarding uninvestigated micro organisms 
because the ‘limited’ information they possess 
does not fit into the currently accepted practice 
of gen erating and publishing scientific informa-
tion within a ‘single packet’ of data. These data 
packets (usually scientific publications) tend 
to possess a strictly defined structure, which 
sequentially include: a definition of the problem 
(introduction); a definition of the techniques 
used to investigate the problem (materials and 
methods); a definition of the results (results); 
and the placement of the findings into a specific 
context, including possible pitfalls of the research 
“Currently, it is the final 
part of the structure of 
these scientific data 
packets that dominates 
scientific thinking, that is, 
data have to be placed into 
a ‘short-term’ context 
(regional, global or 
chronological) in order to 
have a publishable or 
usable scientific value.”
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itself and suggestions for future research objec-
tives (discussion and conclusion). Currently, it is 
the final part of the structure of these scientific 
data packets that dominates scientific thinking, 
that is, data have to be placed into a ‘short-term’ 
context (regional, global or chronological) in 
order to have a publishable or usable scientific 
value. This emphasis on contextualization is very 
similar to that which occurs when producing a 
movie or writing a book. An emphasis on context 
is used to interest the viewer or reader in order 
to provide entertainment, and ultimately to 
generate sales of the product. Without some 
form of contextualization, the movie or film 
would appear to be unfinished and generate 
fewer readers or sales. Within the context of 
scientific advances and the role of data-poor 
microorganisms, the question therefore remains 
as to whether current scientific research and pub-
lishing dogma is actually ‘fit-for-purpose’ and 
synergizes or antagonizes with our current sci-
entific capabilities and future scientific needs? 
Is this dogma actually generating hurdles to 
possible future scientific breakthroughs and the 
advancement of knowledge by relying too much 
on packaging and short-term contextualization 
in order to sell scientific articles as short stories? 
After all, the more interesting the story, the 
higher the article impact and the increase in cita-
tions and author recognition! Therefore, even 
in an era of open access publishing and ‘author 
pays’ financial models, it is doubtful that journal 
editors will be persuaded to publish scientific 
research based on data-poor microorganisms.
Another important point is that the perceived 
value and job security of scientists are becoming 
more and more based on ‘excellent’ research 
that quickly generates short-term interest for 
members of the scientific community, journalists, 
politicians or the general public. So-called ‘blue 
sky’ and long-term research have become less 
compatible (and at the same time less financially 
attractive in the short term) than research that 
can quickly be patented to generate profit or 
high-impact publications. Research into data-
poor microorganisms does not fit within this 
pattern of ‘short-termism’, especially in an era 
where research funding is under pressure and 
priorities have to be made with respect to global 
research agendas. Having said that, the author 
feels that there is still a case for research into 
data-poor microorganisms to be funded and to 
be published. Instead of simply taking a short-
term view, we need to find ways to encourage 
microbiologists to share and study data-poor 
isolates, while at the same time encouraging 
scientific journals to publish the results obtained.
Finally, when we talk about the develop-
ment and understanding of many different 
aspects of science and culture, we often refer 
to the past, for example, the development of 
vaccination, antibiotics, flight, fashion, music, 
the Internet etc., as occurring within various 
decades (e.g., within the 1950s, 60s, 70s and 
80s) or even within various centuries (e.g., the 
1700s, 1800s etc.). Although important scien-
tific and cultural events in themselves, the fact 
that these events are now ‘aged’ (more than 
10 years old), means that not being able to define 
an exact month or year when the events occurred 
does not necessarily significantly impact on 
the context or value of the development of the 
knowledge being described. Alternatively, the 
publication of ‘epidemiologically poor’ data lack-
ing accurate chronological context (e.g., day, 
month etc.) does not significantly impact on 
the relationship between the past and current 
contextualization of the events being described, 
that is, the meaning of these developments to 
the current context of science, fashion, music 
etc., is not lost, but placed into a relative (non-
short-term) context with respect to the greater 
range of time that has passed. Additionally, in a 
global context, the significance of regional data 
tends to become less significant when national 
or international data are especially relevant. For 
example, considering a microbiological example, 
involving global microbiological ‘outbreak 
events’, scientists are happy to publish their 
results based on national rather than regional 
findings. One example of this is the reporting 
of the NDM-1 resistance gene, where regional 
considerations were not considered important 
within the context of global events [4,5]. In 
these cases, the generation and publication of 
low-fidelity findings obtained from data-poor 
microorganisms may outweigh the need for 
epidemiologically rich, regional-based data.
Added value
So if data-poor isolates are to be dusted off and 
included in relevant microbiological research 
studies, what type of experiments should be 
performed and how should the data obtained 
be incorporated into modern day knowledge 
regarding the origin and spread of (patho-
genic) microorganisms at the regional, national 
and global level? One of the most powerful 
“Importantly, although it is 
tempting to think of the 
added value of data-poor 
microorganisms as being 
restricted to research and 
publications involving 
comparative genome 
sequencing, there actually 
exist many more 
possibilities for research 
involving data-poor 
microorganisms.”
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techniques currently in use in microbiology is 
WGS and this seems to be the most logical and 
useful place for utilizing data obtained from 
data-poor microbial specimens (see also whole-
genome multi-locus sequence typing above). 
WGS facilitates the identification and mapping 
of core, accessory, virulence and antibiotic 
resistance genes, as well as facilitating research 
into the colonization, global spread and patho-
genicity of bacterial clones. The use of WGS 
on data-poor microbial isolates could reveal 
unknown or unappreciated (but potentially 
pathogenic) genes that have ceased to circulate 
or are currently circulating ‘under-the-radar’ 
in microbial clones. In this respect, ‘under-
the-radar’ means that the genes are present in 
microbial populations, but that they have not 
yet been discovered due to the limited number 
of WGS studies that have currently been per-
formed on circulating global isolates. Also very 
important, the genetic data obtained from data-
poor microorganisms can be incorporated into 
current WGS studies to generate more complete 
views of genetic shifts in microbial clones with-
out having to link the isolates to a specific point 
of time. A detailed genetic map obtained from 
data-poor isolates and current microbial clones 
could indicate a loss or gain of genetic informa-
tion between a data-poor isolate and a currently 
circulating strain, providing micro biologists 
with a targeted focus for future research. 
For example, WGS of data-poor isolates of 
Escherichia coli obtained approximately 30 years 
ago in Rotterdam, The Netherlands could be 
compared with a modern day Escherichia coli 
isolates obtained from Rotterdam in December 
2017, this as a basis for investigating the loss 
or gain of antibiotic resistance genes within the 
Rotterdam area over the previous 30 years. The 
age difference between the data-poor micro-
organisms investigated neutralizes the per-
ceived need for epidemiologically rich data in 
the contextualization of the results.
Importantly, although it is tempting to think 
of the added value of data-poor microorganisms 
as being restricted to research and publications 
involving comparative genome sequencing, 
there actually exist many more possibilities for 
research involving data-poor microorganisms. 
These include (to name only a few) – patho-
genicity studies: investigating the patho genicity 
of historically significant microorganisms [6], 
discovery of variation in (unknown) mobile 
genetic elements [7], discovery of variation in 
(unknown) virulence factors and plasmids [8], 
identif ication of new antibiotic/antiviral/
antifungal/antiparasitic mechanisms and 
anti biotics [9], investigating antibiotic ‘toler-
ance’ [10], transformation, transduction, conju-
gation efficiencies [11]; diagnosis and treatment: 
development of new diagnostic tests and tar-
gets [12], discovery of previously unknown anti-
biotics [13], investigating microorganisms and 
cancer therapy [14], extended standardization of 
genotyping schemes [15]; gene regulation: investi-
gating global gene regulation, for example, SOS 
and stringent responses [16], linking transcrip-
tion factors to global physiology [17], reconstruc-
tion and prediction of transcription regulatory 
networks [18]; evolution: evolutionary eco-
logical transitions [19]; and the immune system: 
differences in inflammatory responses [20].
The results obtained from this kind of 
research are actually data-independent in that 
all of the epidemiological data necessary to 
generate scientific value and publishable results 
are contained within the actual data-poor 
micro organism itself. Providing a context for 
the data provides an extra level of interest to 
the results, but is not by itself mandatory for 
generating added value.
The solution
If we accept that data-poor microorganisms 
currently represent a large, but untapped, 
resource of underused yet potentially invalu-
able scientific data, then we should take the 
necessary steps to inventorize, analyze and 
even biobank these data-poor isolates (or at 
least biobank the data obtained from these 
data-poor micro organisms) for future gen-
erations [21]. This process will invariably 
require the integration of scientific collabo-
ration, funding and technological (e.g., bio-
informatics) expertise, which could eventu-
ally be obtained via multinational or national 
funding calls. However, other options do 
exist, including the generation and pooling 
of data-poor microorganisms/data between 
individual institutions, such that consortia of 
institutions can pool their resources, while at 
the same time sharing the burden of the overall 
costs of the research involved. Alternatively, 
data-poor microorganisms could be potentially 
interesting for pharmaceutical companies to 
investigate, and license agreements or material 
transfer agreements could be arranged on an 
individual institution basis.
“Scientists and scientific 
journal editors need to 
think about how 
collaborative agreements, 
financial support and 
research expertise can be 
best integrated into an 
international approach 
designed to make best use 
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Whichever (if any) of these collaborative solu-
tions become available, it will be necessary to 
establish some form of data exchange that will 
publicize the availability of data-poor micro-
organisms and the willingness of (academic) 
laboratories to collaborate in sharing isolates, 
obtaining funding, processing data and pub-
lishing the results obtained. In this respect, 
the author has established a basic online web-
site [1], in order to encourage contact details to 
be exchanged between institutions or individual 
scientists that are interested in publicizing their 
data-poor microorganisms or expertise.
Conclusion
Data-poor microorganisms are a precious 
resource of genetic and phenotypic microbial 
information that are currently being under-
utilized and are threatened with extinction. 
Scientists and scientific journal editors need 
to think about how collaborative agreements, 
f inancial support and research expertise 
can be best integrated into an international 
approach designed to make best use of these 
valuable ‘once-lost-gone-forever’ resources. 
Scientists and scientif ic journals should 
re-think the current emphasis on the short-
term contextualization of research data and 
accept imprecisely defined data-poor contexts 
in exchange for the acquisition of long-term 
insights into microbial genomics, transcrip-
tomics, metabolomics, virulence and microbial 
evolution. Publishing scientific data and the 
dissemination of information and hypotheses 
is the true driver of the progression of (micro-
biological) science. By denying the acceptance 
of data-poor science, we are literally throwing 
away a potential resource of new knowledge, 
insight and novel scientific development.
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